Details of the Drug Excipient
General Information of Drug Inactive Ingredient (DIG) (ID: E00065)
| DIG Name |
Pentetic acid
|
||||
|---|---|---|---|---|---|
| Synonyms |
Pentetic acid; diethylenetriaminepentaacetic acid; 67-43-6; DTPA; Detapac; Detarex; Complexon V; Titriplex V; Perma kleer; Monaquest CAI; Hamp-Ex Acid; Penthanil; Dabeersen 503; CHEL 330 acid; Pentacarboxymethyldiethylenetriamine; Diethylenetriamine Pentaacetic Acid; Chel DTPA; Penthamil; H5dtpa; (Diethylenetrinitrilo)pentaacetic acid; Diethylenetriamine-N,N,N',N'',N''-pentaacetic acid; Glycine, N,N-bis[2-[bis(carboxymethyl)amino]ethyl]-; DETPA; N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine; Glycine, N,N-bis(2-(bis(carboxymethyl)amino)ethyl)-; Monaquest; Pentetate; 1,1,4,7,7-Diethylenetriaminepentaacetic acid; NSC 7340; UNII-7A314HQM0I; MFCD00004289; 2-[bis[2-[bis(carboxymethyl)amino]ethyl]amino]acetic acid; Diethylenetriaminepentacetic acid; DTP-A; 3,6,9-Triazaundecanedioic acid, 3,6,9-tris(carboxymethyl)-; N,N-bis[2-[bis(carboxymethyl)amino]ethyl]glycine; N,N-Bis(2-(bis-(carboxymethyl)amino)ethyl)-glycine; 7A314HQM0I; Chel 330; Diethylenetriaminepentaaceticacid; Acetic acid, ((carboxymethylimino)bis(ethylenenitrilo))tetra-; CHEBI:35739; NSC7340; (Diethylenetriamine)pentaacetic acid; Diethylene triamine pentaacetic acid; N,N-Bis(2-(bis(carboxymethyl)amino)ethyl)glycine; NSC-7340; Acetic acid, 2,2',2'',2'''-(((carboxymethyl)imino)bis(2,1-ethanediylnitrilo))tetrakis-; Diethylenetriaminepentaacetic acid;DTPA; CAS-67-43-6; NCGC00015360-05; (((Carboxymethyl)imino)bis(ethylenenitrilo))tetraacetic acid; Dissolvine D; DSSTox_CID_3434; Acidum penteticum; DSSTox_RID_77025; DSSTox_GSID_23434; N,N-Bis(2-[bis(carboxymethyl)amino]ethyl)glycine; Penthamil (VAN); N,N,N',N'',N''-diethylenetriaminepentaacetic acid; [[(Carboxymethyl)imino]bis(ethylenenitrilo)]tetraacetic acid; Acido pentetico; Acide pentetique; [[(carboxymethyl)imino]bis(1,2-ethanediylnitrilo)tetraacetic acid]; 2,2',2'',2''',2''''-(ethane-1,2-diylnitrilo)pentaacetic acid; C14H23N3O10; Diethylenetriaminepentaacetic acid, 99%; Diethylenetriaminepentaacetic acid, 98+%; Acide pentetique [INN-French]; Acido pentetico [INN-Spanish]; Acidum penteticum [INN-Latin]; SR-01000075826; EINECS 200-652-8; BRN 1810219; 2-(bis{2-[bis(carboxymethyl)amino]ethyl}amino)acetic acid; Acetic acid, [(carboxymethylimino)bis(ethylenenitrilo)]tetra-; pentetic-acid; N-Carboxymethyliminobis(ethylenenitrilo)tetra(acetic acid); Acetic acid, 2,2',2'',2'''-[[(carboxymethyl)imino]bis(2,1-ethanediylnitrilo)]tetrakis-; Penta(carboxymethyl)diethylenetriamine; Pentetic acid [USAN:USP:INN:BAN]; 2,2'-(Carboxymethylimino)bis(ethyliminodiessigsaeure); Pentetic acid; DTPA; DTPA (Pentetic Acid); Plexene D (Salt/Mix); Syntron C (Salt/Mix); Kiresuto P (Salt/Mix); Tetralon B (Salt/Mix); Prestwick0_000941; Prestwick1_000941; Prestwick2_000941; Prestwick3_000941; Lopac-D-6518; Chel 330 (Salt/Mix); CHEMBL780; EC 200-652-8; Pentetic acid (USP/INN); Lopac0_000431; SCHEMBL17138; BSPBio_000902; 4-04-00-02454 (Beilstein Handbook Reference); SPBio_003061; BPBio1_000994; (Carboxymethylimino)bis(ethylenenitrilo)tetraacetic acid; DTXSID2023434; HMS1570N04; HMS2094E03; HMS2097N04; HMS3261G04; HMS3714N04; Pharmakon1600-01506082; Tox21_110131; Tox21_500431; AC-333; BBL002988; NSC759314; s4824; SBB008753; STK373226; ZINC19419017; WLN: QV1N1VQ2N1VQ2N1VQ1VQ; AKOS005446652; Tox21_110131_1; CCG-204523; DB14007; LP00431; LS41179; MCULE-4554913963; NSC-759314; SDCCGSBI-0050416.P003; NCGC00015360-01; NCGC00015360-02; NCGC00015360-03; NCGC00015360-04; NCGC00015360-06; NCGC00015360-08; NCGC00015360-09; NCGC00015360-12; NCGC00093852-01; NCGC00093852-02; NCGC00093852-03; NCGC00261116-01; AK109574; M299; VS-01284; SBI-0050416.P002; 1,4,7,7-Diethylenetriaminepentaacetic acid; AB00375916; CS-0013088; D0504; EU-0100431; FT-0624901; ST50868315; D 6518; D05422; Diethylenetriaminepentaacetic acid, p.a., 99%; AB00375916-04; AB00375916_05; Diethylenetriamine-N,N',N'',N''-pentaacetic acid; Glycine,N-bis[2-[bis(carboxymethyl)amino]ethyl]-; Q416487; N,N-bis {2-[bis(carboxymethyl)amino]ethyl}glycine; SR-01000075826-1; SR-01000075826-4; BRD-K40621224-001-01-8; Diethylenetriaminepentaacetic acid, >=98% (titration); Diethylenetriaminepentaacetic acid, >=99% (titration); N, {N-Bis[2-[bis(carboxymethyl)amino]ethyl]glycine}; Glycine, {N,N-bis[2-[bis(carboxymethyl)amino]ethyl]-}; 3,9-Triazaundecanedioic acid, 3,6,9-tris(carboxymethyl)-; (((Carboxymethyl)imino)bis(ethylenenitrilo))-tetraacetic acid; {[[(Carboxymethyl)imino]bis(ethylenenitrilo)]tetraacetic} acid; 2-[bis({2-[bis(carboxymethyl)amino]ethyl})amino]acetic acid; Acetic acid, {[(carboxymethylimino)bis(ethylenenitrilo)]tetra-}; Diethylenetriaminepentaacetic acid, for complexometry, >=99.0%; Pentetic acid, United States Pharmacopeia (USP) Reference Standard; Acetic acid,2',2'',2'''-[[(carboxymethyl)imino]bis(2,1-ethanediylnitrilo)]tetrakis-; 1004765-76-7; 2,2',2'',2'''-(2,2'-(carboxymethylazanediyl)bis(ethane-2,1-diyl)bis(azanetriyl))tetraacetic acid; 2-{[2-({2-[bis(carboxymethyl)amino]ethyl}(carboxymethyl)amino)ethyl](carboxyme thyl)amino}acetic acid
|
||||
| DIG Function |
Antimicrobial preservative; Complexing agent
|
||||
| Formula |
C14H23N3O10
|
||||
| Canonical SMILES |
C(CN(CC(=O)O)CC(=O)O)N(CCN(CC(=O)O)CC(=O)O)CC(=O)O
|
||||
| InChI |
1S/C14H23N3O10/c18-10(19)5-15(1-3-16(6-11(20)21)7-12(22)23)2-4-17(8-13(24)25)9-14(26)27/h1-9H2,(H,18,19)(H,20,21)(H,22,23)(H,24,25)(H,26,27)
|
||||
| InChIKey |
QPCDCPDFJACHGM-UHFFFAOYSA-N
|
||||
| Physicochemical Properties | Molecular Weight | 393.35 | Topological Polar Surface Area | 196 | |
| XlogP | -8.5 | Complexity | 481 | ||
| Heavy Atom Count | 27 | Rotatable Bond Count | 16 | ||
| Hydrogen Bond Donor Count | 5 | Hydrogen Bond Acceptor Count | 13 | ||